This invention relates a process for manufacturing a tablet using a fluent, settable matrix
The use of waxes or polymers as matrix components in pharmaceutical compositions holds potential advantages which include the following: formation of solid solutions or solid suspensions; improved absorption and efficacy of poorly water-soluble substances; improved bioavailability; reduced dosing frequency; no solvents; GRAS (generally regarded as safe) status of matrix components, and thus suited for natural health products; single, continuous process manufacture; environmentally friendly; improved content uniformity due to intense mixing; components of polymer/wax matrix may act as thermal binders, drug stabilizers or solubilizers; lower risk of dose dumping; lower temperatures than hot melt extrusion; improved stability; reduced dosing frequency; multi-release possibility; and tailored release profiles.
The judicious selection of matrix components allows for the manipulation of the release rate of an active component from the matrix, and the creation of tailored release profiles. This can result in reduced dosing frequency, and improved patient compliance, as well as fast onset or sustained release systems. The correct choice of matrix components (from amongst others: binders, solubilizers, stabilizers, polymers, waxes and surfactants) may also allow improved bioavailability of an active formulated in the matrix, as well as improved stability of the end product. The absorption and efficacy of poorly water-soluble compounds may be increased.
The manufacture of a tablet using wax, polymer or a similar settable material can be problematic. For example if an injection moulding process is used then the effects of viscosity and surface tension of a molten wax mixture present technical difficulties. Another technique, referred to as a hot melt extrusion process, is carried out at relatively high temperatures, with the risk of API (Active Pharmaceutical Ingredient) degradation, and often requires subsequent granulation and compression of the extrudate into final tablets.
Other technologies for the manufacture of wax-based dosage forms require a process of granulation (with solvent) and subsequent compression of a granulate into tablets. Variations in granule size may cause challenges in the pressing of tablets and binders are required for tablet formation. Also, API particle distribution may not exhibit a desirable level of uniformity.
One of the challenges of each of these technologies, to the applicant's knowledge, lies in the provision, in a relatively easy manner, of a single tablet which has multiple release capabilities.
The present invention is concerned with a method of making a tablet from a fluent settable matrix which at least in a preferred embodiment, allows many of the aforementioned benefits to be achieved.
The invention provides a method of making a tablet which includes the steps of providing a mould cavity which faces upwardly and which has a lower section with a defined shape and size, preparing a settable fluent matrix, placing a predetermined quantity of the fluent matrix in or on the mould cavity, controlling at least one variable parameter to cause an upper surface of the fluent matrix to assume substantially the defined shape and size of the lower section, and allowing the fluent matrix to solidify into a body which has an upper portion which has substantially the defined shape and size determined by the control of the at least one variable parameter.
The matrix may be temperature settable i.e. it sets (solidifies) when its temperature drops below a defined level.
Preferably the at least one variable parameter is selected at least from the following:
a) the composition of the matrix;
b), the temperature of the matrix;
c) the viscosity of the matrix; and
d) the rate at which the temperature of the matrix is lowered.
The magnitude of the predetermined quantity i.e. the volume of the fluent matrix has a material bearing on the shape and size of the upper surface of the body and is therefore precisely controlled and is adjusted as is necessary if the composition of the matrix is altered in a way which affects the setting thereof.
It is possible to form the mould cavity so that letters, logos and the like are formed in at least an outer surface of the lower portion of the solidified body. Markings of this type, which generally are of a marketing or identifying nature, are not regarded as forming part of the defined shape and size of the lower section of the mould cavity.
In one form of the invention the mould cavity is directly contacted by the fluent matrix and, upon solidification of the matrix, the lower section of the mould cavity causes a lower portion of the body to have the defined shape and size.
In a different form of the invention the predetermined quantity of the fluent matrix is placed over or adjacent at least one fluent composition previously placed in or on the lower section of the mould cavity and which has then been allowed to set. A lower portion of the at least one composition then has the defined shape and size as determined by the shape and size of the lower section.
In one preferred embodiment of the invention the mould cavity has the lower section which has the defined shape and size and an upper section which has a side wall.
In one form of the invention the side wall, during implementation of the method, is generally vertical.
The side wall is shaped to ensure that the tablet will readily be released, e.g. ejected, from the mould cavity once the matrix has set. This release must be accomplished without adversely affecting the desired tablet shape.
A surface of the side wall at a mouth of the mould cavity may subtend an angle, to a surface surrounding the mould cavity, of from 90° to 110°. At least part of the side wall, viewed from one side, may be concave or in the shape of a shallow V or, more generally, may be slightly undercut. The side wall shape is determined, at least, by the requirement that the tablet must be readily releasable from the mould cavity; a characteristic which, in turn, is dependent at least on the nature of the material (e.g. its resilience and elasticity) which defines the mould cavity.
By careful control of the at least one variable parameter the upper portion of the body is caused to take on the defined shape and size. The lower portion of the body has the defined shape and size, as determined by the lower section of the mould cavity. A portion of the body, between the upper and lower portions, has a size and shape determined by the side wall of the mould cavity.
Without being bound by the following explanation the applicant has proceeded on the basis that if the temperature of the fluent matrix when placed in or on the mould cavity is sufficiently high, then its viscosity is reduced and surface tension effects exhibited in the fluent matrix are substantially reduced. Conversely as the temperature is decreased surface tension effects become more pronounced and the convexity or roundness of the upper surface of the fluent matrix increases. This process can also help to contain the fluent matrix so that it does not spill over from the mould cavity. The control step is then used to regulate the temperature and viscosity of the matrix (characteristics which are dependent, at least, on the composition of the matrix) to achieve, in a repeatable manner, the defined shape and size of the upper portion of the tablet. Primarily this is done to ensure that the tablet has a symmetrical shape i.e. with the upper portion substantially the same as the lower portion.
Features such as the speed at which the fluent mixture is placed into the mould cavity, and the speed of movement of the mould cavity, while the matrix is setting, are readily determined by experimentation and observation, in practice, for each particular composition.
The temperatures at which the sought-after shapes are achieved can be determined, with relative ease, through experimentation. These temperatures depend, at least, on the composition of the fluent matrix. It is then possible to shape at least the lower section of the mould cavity accordingly. Consequently during tablet manufacture if the temperatures and other variables are reproduced the upper portion of the tablet has essentially the same shape and size (as determined by parameter control) as the lower portion (as determined by the shape and size of the lower section of the mould cavity). If a small change takes place in the composition of the matrix then a mould cavity of a given size and shape can still, in most instances, be used successfully by making small adjustments to the relevant parameters.
In order to achieve one or more of the aforementioned potential advantages and to produce a fluent matrix which is susceptible to parameter control so that the upper surface of the fluent matrix takes on a predetermined shape and size, use may be made of at least one of the following settable substances: suitable waxes such as beeswax, candellila wax, carnauba wax, rice bran wax, paraffin wax, and micro-crystalline wax, and suitable polymers, gums and gels.
Any appropriate active ingredient or ingredients may be included in the fluent matrix which thus acts as a carrier. The active ingredient may be one or more of the following: a pharmaceutical active or drug, a vitamin, a mineral and, in general, any selected product or ingredient.
The matrix may optionally include a release modifying or release controlling agent which may be selected from at least the following: polyvinyl pyrrolidone; polyethylene glycol; hydroxypropyl methylcellulose or any alternative vegetable cellulose derivative; and Gelucire (trade mark—manufactured by Clariant). The active ingredient included in the matrix may, itself, act as a release modifying agent.
Additional ingredients to be included in the matrix to enhance its properties may be selected from at least the following: emulsifiers, solubilizers, stabilizers, thickeners and surfactants such as sucrose monopalmitate.
The shape of the upper portion of the matrix, as setting (cooling) takes place, can be influenced by a number of other factors. The rate of cooling of the matrix can for example produce distortion. If the cooling rate is too high distortion may occur. To address this it falls within the scope of the invention to use a mechanism which regulates the cooling rate in order to minimize distortion. Similarly, the composition of the matrix usually has an effect on the shape of the upper surface of the solidified matrix. Carnauba wax, for example, deforms substantially upon cooling whereas beeswax is not as prone to distortion. A mixture of these components can be used to produce a product which is not particularly susceptible to distortion and which has an acceptable end shape and surface qualities i.e. not sticky.
The mould cavity may be one cavity of a plurality of cavities formed in a substrate which is made from a flexible material of suitable characteristics e.g. rubber or a similar synthetic material. In this form of the invention the body, once solidified, may be ejected or otherwise removed from the mould cavity for subsequent packaging, bottling or the like. It is important in this respect to ensure that the mould cavity has a shape which does not impede removal of a tablet from the cavity. In this regard it is also necessary to take into account the nature of the material used to define the mould cavity e.g. the flexibility of the material.
In an alternative form of the invention the body, upon solidification, is left in the mould cavity which is formed in a first packaging element. Thereafter a second packaging element is superimposed on the first packaging element, to extend over the solidified body, and the packaging elements are secured together to form an enclosure for the solidified body. This process may be effected substantially simultaneously for a number of mould cavities and continuously along the lengths of the packaging elements. Any appropriate packaging elements may be used, e.g. blister pack components.
The last mentioned form of the invention thus eliminates a manufacturing step and the need for a reusable, separately formed mould. This reduces costs and increases efficiency.
A composition which has been formulated and manufactured in the described way results in high content uniformity, i.e. an even and fine distribution of the active ingredient or ingredients in the final product, effectively a solid solution or a solid-suspension or -dispersion. The choice of matrix components from a range of ingredients with GRAS status (particularly waxes, such as beeswax), allows for the use of this technology in the manufacture of products for the natural health products (or nutriceutical) market, and may also reduce regulatory challenges in the pharmaceutical environment. Wax- or polymer-based tablets can be manufactured as floating tablets, and can also reduce the risk of dose dumping.
The manufacture of wax- or polymer-based matrix tablets as contemplated herein requires no solvents, is environmentally friendly, and can be performed in a single continuous process.
The invention is further described by way of examples with reference to the accompanying drawings in which:
The apparatus includes a mixing container 12 with a mixer blade 14 or a similar device which is driven by a controllable motor 16. A measured quantity of a settable material 20, which is used as a carrier, is placed into the container 12 by means of a control device 22 such as a valve. A metered quantity of an active ingredient or ingredients 24 is placed into the container through a control device 26. Heat from a source 30, which may use electrical elements or gas, is used to raise the temperature of the container 12 and its contents in a controlled way.
A positive displacement pump 34 is used to convey fluent material from the container to a dispenser 36 which is one of a plurality of similar devices, not shown, positioned above a conveyor belt 42 which is movable in a regulated manner by means of a suitable drive motor 44. A mould cavity 46, which is one of a number of similar cavities, is formed in an upper surface 48 of the conveyor belt and is locatable directly below the dispenser 36.
The belt 42 is made from a flexible material with suitable characteristics such as rubber or a similar synthetic material.
The pump 34 operates through a regulator 50 which controls the pressure in the dispenser 36. Excess material delivered to the regulator is returned to the container through a line 52.
The dispenser 36 includes a cylinder 60 with an entry port 62 which is connected to a line 64 leading from the regulator 50. A piston 66 is reciprocally mounted in the cylinder and is movable by means of an external actuator 70, the operation of which is linked to the speed of movement of the conveyor belt. The cylinder is rotatable about a horizontal axis 72. At one end the cylinder has a nozzle 74. The operation of the dispenser is such that, when the nozzle faces upwardly, material from the container is pumped into the cylinder via the port 62. This is with the piston withdrawn. Thereafter, when the nozzle faces downwardly, the piston is operated to expel the content of the cylinder through the nozzle into the upwardly facing mould cavity 46. Indexing techniques are used to ensure that discharge from the nozzle is accurately controlled relative to the speed of movement of the conveyor belt and the position of the mould cavity.
The various components are connected to a computer-based unit 76 which controls, at least, the mixing process, the heating of the container, the working of the pump, the movement of the conveyor, and the operation of the actuator and of the dispenser.
The fluent matrix may be prepared using any suitable apparatus and the aforegoing description is exemplary only and non-limiting.
The mould cavity, viewed from one side, has a lower section 80 with a dished or concave profile, and an upper section 82 with a side wall 84 which, in use, is generally vertical and at a right angle to the upper surface 48 of the conveyor belt. The shape of the lower section is largely determined by measuring the shapes of upper body portions of different formulations and different volumes, of temperature settable, fluent matrixes (of the kind described hereinafter) which are allowed to solidify under various sets of controlled conditions.
The shape of the mould cavity as depicted in
In use of the apparatus wax 20 of a suitable grade is placed in a precisely measured quantity via the control device 22 into the container 12. The temperature of the container is increased by the heating source 30 to melt the wax. From empirical data and operating parameters determined previously the temperature of the fluent matrix is precisely controlled taking into account at least the nature of the composition of the matrix. Thereafter a measured quantity of active ingredients 24, selected for example from vitamins, trace elements and pharmaceutical compositions, is added to the molten wax via the control device 26. Release control and modifying agents and stabilizers, emulsifiers, thickeners, surfactants and stabilizers are also included according to requirement. The mixer 14 is activated to ensure that all the materials inside the container are thoroughly mixed to produce a composition which includes the same constituents, in the same amounts, and which is at the same temperature, as a selected formulation which was employed when the shape and size of the lower section of the mould cavity were determined. Small adjustments to these variables can however be made, as required, to take account of any effects resulting from a minor variation in the makeup of the composition.
Once the molten matrix has been prepared the pump 34 is operated to pump the matrix to the dispenser. When the discharge nozzle 74 is directly positioned above the mould cavity 46 the actuator 70 is operated. The volume of the fluent matrix which is dispensed and other operating parameters are carefully controlled to ensure that a precisely metered volume of the matrix is placed in the mould cavity. The excess material forms an upwardly extending bead which projects above the surface 48 of the conveyor belt around the mould cavity and which defines an upper portion of a tablet which is being formed. By carefully controlling and repeating the various parameters which were initially used to determine the shape and size of the lower section of the mould cavity, the upper portion of the tablet is caused to take on substantially the same shape and size as the lower portion of the tablet.
The rate of cooling of the fluent matrix in the mould cavity can be controlled in any appropriate way, e.g. by the application of hot or cold air which is directed from a source 90 onto a zone 92 through which the belt is passed.
The tablet 94, when it reaches a discharge end of the conveyor belt, can be ejected by causing the belt to pass over a forward roller 96, of relatively small diameter, as shown in
Each tablet could be coated with any required material using a suitable technique known in the art. It is possible to form a tablet from two or more mixtures, each deposited in fluent form, one over the other, into a mould cavity, from different dispensers. In a variation of the invention solid, separately formed components of any appropriate composition are placed into a mould cavity, optionally on top of fluent material already in the cavity, and are then covered with fluent material, generally in the manner described, which is allowed to set.
In the preceding description the tablet 94 is formed in a reusable mould cavity and, upon ejection from the mould cavity, the tablet is collected for packaging purposes. In another form of the invention appropriate mould cavities are directly formed in packaging elements in order to obviate the tablet ejection process and to simplify packaging of the tablets.
The element 110 is made from any appropriate material and typically is a suitable plastic material, a foil, or the like. The invention is not limited in this respect.
The installation at the workstation 114 is similar to that shown in
The packaging element 110 is fixed to, or carried by, an appropriate transport mechanism, not shown, such as a conveyor belt. The movement of the transport mechanism is accurately controlled in an indexed manner to bring successive pairs of the depressions 112A, 112B, etc. into register with the nozzles 134 and 136, with the depressions directly underlying the nozzles. The belt is then held stationary for a brief period and, thereafter, the next indexed step of movement takes place.
With the belt stationary a respective metered volume of the fluent tablet matrix 140, from the vessel 116, is discharged through each of the nozzles 134 and 136 into the underlying depressions which act as mould cavities for the mixtures. Each metered volume of tablet matrix cools and then sets as a bead 142 which has a lower portion and an intermediate portion which fill the mould cavity, and an upper portion, which stands proud of the material around the mould cavity, and which is substantially the same in shape and size as the lower portion.
The packaging element may have a defined length and width. Alternatively, the packaging element is provided in elongate form so that the beads 142 are formed on an ongoing basis in a continuous process. Subsequently the packaging element is severed into a plurality of discrete sections, each of a defined size. Preferably this step takes place after the stage shown in
In the stage shown in
Thus, the first packaging element 110 provides mould cavities which help to form the beads 142. The beads are not shaped in a separate mould but, instead, are formed in situ in the relevant packaging material and are retained therein for subsequent dispatch.
The shape of a bead (tablet), as cooling takes place, can be affected by a number of other factors. Reference has been made to the effect of temperature and, depending on the nature of the matrix, the effect can be more or less pronounced. For example the rate of cooling of the bead can influence distortion. If the cooling rate is too high distortion may well occur. To address this possibility it falls within the scope of the invention, as has been referred to in connection with
The tablet matrix can be made from an appropriate mixture of ingredients selected for example from waxes such as beeswax, carnauba wax, and microcrystalline wax, polymers, release-controlling or-modifying agents, surfactants, stabilizers, solubilizers and so on. The invention is not limited in this regard.
The invention can be implemented in a variety of ways and the preceding descriptions are by way of examples only. For example the packaging element can be carried by a conveyor belt or other transport mechanism. In a variation of the invention the packaging element itself is driven by a suitable drive arrangement and is moved over underlying structure. This approach eliminates the need for a separate conveyor belt. A lubricant can be used, if required, on the packaging element to facilitate its smooth passage past the workstation. If necessary use can be made of a release agent which is applied to relevant surfaces, at least of the packaging element 110, to facilitate the easy release, when required, of a tablet which, possibly, is sticky or which otherwise has a tendency to adhere to the surface of the packaging element in which it is formed.
To enable a user to grip a tablet it is advantageous if each depression 112 is formed with a surrounding ledge 160 which is recessed relative to an upper surface 162 of the surrounding material of the first packaging element. The recessed surface can also assist with optimal formation of the tablet, and provides clearance between the tablet and the second packaging element.
At relatively high temperatures a bonding effect between adjacent layers of the matrix is enhanced. If a lower layer has cooled prior to the application of a hotter, upper layer then an indentation may occur at a surface of the boundary between the layers. This type of unwanted effect can be addressed by manipulating temperatures or the compositions of the matrix.
Some ingredients which may be fat-or water-soluble are inclined to dissolve, substantially completely and evenly, in a wax carrier. The reason why these ingredients dissolve, or go into suspension, is not known to the applicant. Certain ingredients melt at known temperatures and this feature allows these ingredients to be easily mixed with the waxes. Some ingredients go into suspension easily. Other ingredients need to be stirred vigorously to go into suspension. There may be additives that can induce ingredients to go into suspension more readily. These characteristics can be used to facilitate preparation of the matrix.
The technique described in connection with
In
In
In each case when the belt passes over a small roller, as described in connection with
As the angle 250 is reduced to below 90° there is an increasing tendency for surface tension effects to be diminished and, when this occurs, the fluent mixture can spill over onto the surrounding surface of the belt and produce a tablet which has an incorrect shape.
Other forms of the invention can be devised which, although making use of the inventive principles contained herein, could result in a tablet which has a different construction from what is described or illustrated herein. Without being exhaustive the following types of construction are included in the scope of the invention:
a) a tablet which has two or more overlying layers of the same or different constituents,
b) a tablet in which one or more small pellets or beads which, optionally, are preformed, are embedded wholly or partially in one or more fluent layers which are allowed to set,
c) a tablet wherein a first layer of a settable medium carries one or more preformed pellets or beads which are covered by a second layer of a fluent medium, allowed to set in situ, which bonds to the first layer,
d) a tablet wherein two or more pellets or beads, optionally preformed, with the same or different active ingredients, are held together by a binder e.g. of polymer, a wax or a combination thereof which, optionally, carries one or more active ingredients, and
e) a bead or pellet which carries one or more active ingredients and which is at least partly embedded in one or more layers of a fluent matrix which is allowed to set. For example a capsule which contains an appropriate gel or a freeze-dried or a quick release bead could be encapsulated in the fluent matrix.
The degree of convexity of the upper surface of the fluent matrix can be controlled to a greater or lesser extent of varying one or more of the following: the shape of the mould cavity; the volume of the fluent matrix which is placed in the mould cavity; surface tension effects which depend on viscosity and temperature; and the composition of the matrix which could be a suitable blend of wax, polymer and a release-controlling agent.
The effects of temperature on shaping the upper surface of the tablet are variable. At a high temperature the matrix expands to a greater extent than at a lower temperature. If the matrix is heated to a very high temperature, it shrinks significantly on cooling, causing deformation (indenting) of the upper surface of the tablet. At a lower temperature, the effects of shrinkage are less pronounced, thus enabling the rounded shape of the upper surface of the tablet to be maintained.
The technique which is used to prepare the fluent tablet matrix can have an effect on the ingredients. For example, exposure to an elevated temperature over a prolonged period could be adverse to the ingredients, and it may be desirable to reduce the heat-exposure time to a minimum for a heat-sensitive product and, instead of using a melting vessel, a device such as a heated screw pump or an extruder could be used to produce a fluent matrix in a relative short period of time.
Number | Date | Country | Kind |
---|---|---|---|
2009/05684 | Aug 2009 | ZA | national |
2009/08736 | Dec 2009 | ZA | national |
2010/02780 | Apr 2010 | ZA | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/ZA2010/000045 | 8/16/2010 | WO | 00 | 5/1/2012 |